American International Group, Inc. Cyma Bay Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.63 - $24.47 $92,388 - $178,998	7,315 Added 14.94%	56,268 $1.33 Million
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $18,896 - $30,658	1,740 Added 3.69%	48,953 $729,000
Q2 2023 Aug 04, 2023	BUY	$7.47 - $10.95 $352,681 - $516,982	47,213 New	47,213 $516,000
Q2 2022 Aug 12, 2022	SELL	$1.72 - $3.39 $72,682 - $143,251	-42,257 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $15,021 - $19,739	5,423 Added 14.72%	42,257 $131,000
Q4 2021 Feb 11, 2022	SELL	$3.23 - $4.6 $3,559 - $5,069	-1,102 Reduced 2.9%	36,834 $124,000
Q3 2021 Nov 12, 2021	SELL	$3.47 - $4.42 $3,126 - $3,982	-901 Reduced 2.32%	37,936 $138,000
Q2 2021 Aug 13, 2021	SELL	$3.94 - $4.92 $6,047 - $7,552	-1,535 Reduced 3.8%	38,837 $169,000
Q1 2021 May 07, 2021	BUY	$4.23 - $6.55 $452 - $700	107 Added 0.27%	40,372 $183,000
Q4 2020 Feb 12, 2021	SELL	$5.73 - $9.03 $6,618 - $10,429	-1,155 Reduced 2.79%	40,265 $231,000
Q3 2020 Nov 04, 2020	SELL	$3.32 - $7.24 $3,127 - $6,820	-942 Reduced 2.22%	41,420 $300,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $4.25 $2,234 - $6,736	1,585 Added 3.89%	42,362 $148,000
Q1 2020 May 04, 2020	SELL	$1.25 - $2.02 $2,945 - $4,759	-2,356 Reduced 5.46%	40,777 $60,000
Q4 2019 Feb 05, 2020	SELL	$1.33 - $5.93 $484 - $2,158	-364 Reduced 0.84%	43,133 $85,000
Q3 2019 Nov 08, 2019	SELL	$5.12 - $7.21 $1,546 - $2,177	-302 Reduced 0.69%	43,497 $223,000
Q2 2019 Aug 13, 2019	BUY	$6.05 - $13.66 $35,053 - $79,146	5,794 Added 15.25%	43,799 $314,000
Q1 2019 May 06, 2019	SELL	$8.16 - $13.42 $6,438 - $10,588	-789 Reduced 2.03%	38,005 $505,000
Q4 2018 Feb 13, 2019	SELL	$6.54 - $11.74 $1,955 - $3,510	-299 Reduced 0.76%	38,794 $305,000
Q3 2018 Nov 09, 2018	BUY	$10.88 - $14.52 $7,659 - $10,222	704 Added 1.83%	39,093 $433,000
Q2 2018 Aug 08, 2018	BUY	$10.66 - $14.38 $409,226 - $552,033	38,389 New	38,389 $515,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account